Healthcare Insider Selling: Illumina (NASDAQ:ILMN), Raptor Pharmaceutical (NASDAQ:RPTP), Stryker Corporation (NYSE:SYK), United Therapeutics Corporation (NASDAQ:UTHR), CareFusion Corporation (NYSE:CFN)

Technology Stocks News 19

Illumina (NASDAQ:ILMN) Director Daniel Bradbury sold 2,100 shares of the stock on the open market in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $172.89, for a total value of $363,069.00. Following the sale, the director now directly owns 12,466 shares in the company, valued at approximately $2,155,247. Illumina, Inc. (NASDAQ:ILMN) stock performance was 2.51% in last session and finished the day at $175.23. Traded volume was 1.77million shares in the last session and the average volume of the stock remained 1.78million shares. The beta of the stock remained 0.55. Illumina, Inc. (NASDAQ:ILMN) insider ownership is 1.30%.

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Director Llew Keltner sold 10,000 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $11.21, for a total transaction of $112,100.00. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) rose 6.43 percent to $10.92 Wednesday on volume of 1.01million shares. The intra-day range of the stock was $10.13 to $11.07. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) has a market capitalization of $684.30million.

Stryker (NYSE:SYK) Director Ronda E. Stryker sold 7,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $85.19, for a total value of $596,330.00. Following the completion of the sale, the director now directly owns 174,605 shares in the company, valued at approximately $14,874,600. Stryker Corporation (NYSE:SYK)’s stock on July 09, 2014 reported a increase of 0.06% to the closing price of $83.98. Its fifty two weeks range is $65.48 -$86.93. The total market capitalization recorded $31.74billion. The overall volume in the last trading session was 951,837.00million shares. In its share capital, SYK has 379.09million outstanding shares.

United Therapeutics (NASDAQ:UTHR) CEO Martine A. Rothblatt sold 3,833 shares of the company’s stock on the open market in a transaction that occurred on Thursday, June 26th. The stock was sold at an average price of $87.23, for a total value of $334,352.59. Following the transaction, the chief executive officer now directly owns 140 shares in the company, valued at approximately $12,212. On Wednesday, shares of United Therapeutics Corporation (NASDAQ:UTHR) advanced 0.19% to close the day at $93.16. Company return on investment (ROI) is 11.80% and its monthly performance is recorded as -3.73%. United Therapeutics Corporation (NASDAQ:UTHR) quarterly revenue growth is -1.32%.

CareFusion (NYSE:CFN) Insider Thomas J. Leonard unloaded 1,250 shares of CareFusion stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $45.47, for a total value of $56,837.50. Following the sale, the insider now directly owns 32,053 shares in the company, valued at approximately $1,457,450. CareFusion Corporation (NYSE:CFN) stock performance was 0.38% in last session and finished the day at $44.72. Traded volume was 643,111.00million shares in the last session and the average volume of the stock remained 1.64million shares. The beta of the stock remained 0.93. CareFusion Corporation (NYSE:CFN) insider ownership is 0.20%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone